Pipeline — registered trials by phase
No registered trials in this stage.
No registered trials in this stage.
No registered trials in this stage.
No registered trials in this stage.
No approved products listed under this sponsor in Drugs@FDA (partnered or subsidiary products may be listed elsewhere).
Source: ClinicalTrials.gov (trials where McKesson is lead sponsor; 0 active or completed) and Drugs@FDA (0 approved products). Registry data can include older or partnered programs; the company's own pipeline page is the official list.
SEC filings — insider trading forms excluded
- 8-K2026-10-06Current report (material event)
- 8-K2026-08-28Current report (material event)
- 10-Q2026-08-05Quarterly report
- 8-K2026-08-05Current report (material event)
- 8-K2026-07-24Current report (material event)
- 8-K2026-07-01Current report (material event)
- DEFA14A2026-06-30DEFA14A
- ARS2026-06-12Annual report to holders
- DEFA14A2026-06-12DEFA14A
- DEF 14A2026-06-12Proxy statement
- 8-K2026-06-12Current report (material event)
- SD2026-05-28SD
- 10-K2026-05-08Annual report
- 8-K2026-05-07Current report (material event)
- SCHEDULE 13G2026-04-30SCHEDULE 13G
- 8-K2026-04-28Current report (material event)
- 8-K2026-04-06Current report (material event)
- SCHEDULE 13G/A2026-03-27SCHEDULE 13G/A
- 8-K2026-03-06Current report (material event)
- 8-K2026-03-05Current report (material event)
- S-3ASR2026-02-05S-3ASR
- 10-Q2026-02-04Quarterly report
- 8-K2026-02-04Current report (material event)
- 25-NSE2025-11-1725-NSE
- 10-Q2025-11-06Quarterly report
- 8-K2025-11-05Current report (material event)
- 8-K2025-09-23Current report (material event)
- 8-K2025-09-18Current report (material event)
- 10-Q2025-08-06Quarterly report
- 8-K2025-08-06Current report (material event)
- 8-K2025-08-01Current report (material event)
- DEFA14A2025-07-02DEFA14A
- ARS2025-06-20Annual report to holders
- DEFA14A2025-06-20DEFA14A
- DEF 14A2025-06-20Proxy statement
- 8-K2025-06-09Current report (material event)
- 8-K2025-05-30Current report (material event)
- SD2025-05-30SD
- 424B52025-05-22Prospectus (offering)
- FWP2025-05-20FWP
Source: SEC EDGAR. Forms 3/4/5 and 144 (insider transactions) are intentionally left out.